CompaniesByCap
MRKR
Marker Therapeutics, Inc. (MRKR)
NASDAQ · Healthcare

Marker Therapeutics, Inc. Cash Flow 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010
Operating Activities
Operating Cash Flow-12.0M-10.9M-16.4M-27.0M-27.3M-20.0M-18.3M-14.5M-8.4M-6.5M-4.3M-2.2M-694,583-1.6M-1.3M-925,041
Depreciation & Amort.
Investing Activities
Capital Expenditure374,983147,6680
Free Cash Flow-18.7M-14.6M-8.4M
Financing Activities
Dividends Paid
Stock Buybacks71,710310,4930

Marker Therapeutics, Inc. Cash Flow — FAQ

Marker Therapeutics, Inc. (MRKR) cash flow over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MRKR's cash flow history?

The chart and table above show Marker Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.